Viewing Study NCT06962267


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-01-18 @ 1:20 PM
Study NCT ID: NCT06962267
Status: RECRUITING
Last Update Posted: 2025-05-08
First Post: 2025-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
Sponsor:
Organization: